Navigation Links
Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
Date:2/7/2008

SEATTLE, Feb. 7 /PRNewswire/ -- Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced the appointment of David Drajeske as Director of Business Development.

Drajeske brings more than a decade of business development experience in the life sciences industry. He formerly served as Vice President of Business Development for Helix BioMedix, a publicly traded biotechnology company, from 2004 to 2006. While at Helix, Drajeske was involved in the initiation and negotiation of multiple development collaborations. Prior to Helix, Drajeske served as Manager of Business Development for Immunex Corporation. He has also served as Senior Manager, Business Development and Alliance Management for Thermogen, Inc. and Medichem Life Sciences. Drajeske received an M.S. in Biotechnology from Northwestern University's Kellogg Center for Biotechnology and a B.S. in chemical engineering from Purdue University.

"David will be instrumental in our outreach activities aimed at educating potential partners about Koronis' innovative Viral Decay Acceleration therapeutics," said Donald Elmer, Chairman and interim Chief Executive Officer of Koronis. "His business development experience will be an asset to our Company."

About Koronis

Koronis Pharmaceuticals, Inc. is a privately held biotechnology company developing anti-viral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate, KP-1461 for the treatment of human immunodeficiency virus (HIV), is currently being evaluated in a Phase 2 trial. In addition to KP-1461, the Company has products in development for the treatment of hepatitis C and RSV. For more information on Koronis, please visit http://www.koronispharma.com.


'/>"/>
SOURCE Koronis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
2. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
10. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
11. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... for information (RFI) issued by the Office of the National Coordinator for Health ... experience, and determines if clinically relevant data were available when and where it ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute (WPI) ... of wound healing and tissue regeneration. , The novel method, developed by WPI ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has released ... and Beyond. The paper outlines the key trends that are creating both opportunities ... witnessed a lot of highs and lows as the precision agriculture market has ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... interest organization focused on molecular nanotechnology, announced the winners for the 2015 Foresight ... physicist Richard Feynman, are given in two categories, one for experiment and the ...
Breaking Biology Technology:
(Date:3/14/2016)... 14, 2016 NXTD ) ("NXT-ID" or ... market, announces the airing of a new series of commercials ... of March 21 st .  The commercials will air on ... Squawk on the Street show. --> NXTD ) ... mobile commerce market, announces the airing of a new series ...
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
(Date:3/9/2016)... BEACH GARDENS, Fla. , March 9, 2016 ... identity management authentication and enrollment solutions, today announced ... DigitalPersona ® Altus multi-factor authentication ... IT and InfoSec managers to step-up security where ... Washington, DC . ...
Breaking Biology News(10 mins):